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African	 population	 of	 South	 Africa.	 A	 review	 of	 the	 literature	 revealed	 a	 paucity	 of	 information	
regarding	the	dental	and	craniofacial	manifestations	of	the	disorder	 in	this	ethnic	group.	For	these	
reasons,	 the	central	 theme	of	 this	 thesis	 is	 the	 identification,	documentation	and	analysis	of	 these	
features	in	individuals	with	OI	III	in	the	Black	African	population	of	SA.																																														






A	 total	 of	 64	 Black	 African	 affected	 persons	were	 assessed.	 In	 addition	 5	 persons	 of	 Cape	Mixed	
Ancestry	(CMA)	and	3	Indian	individuals	were	investigated.		
With	 the	support	and	co-operation	of	clinical	 colleagues	 in	Pietermaritzburg,	Durban	and	 the	Free	
State,	patients	with	OI	III	who	were	under	their	care,	were	accessible	to	the	author.	











the	 homozygous	 mutation,	 FKBP10_HOM_c.[831dupC][831dupC],	 3	 persons	 with	 the	 compound	




Dentinogenesis	 imperfecta,	 in	 terms	of	clinical	discolouration	of	 teeth,	was	present	 in	 the	primary	
dentition	of	35	Black	African	persons	with	the	unknown	molecular	status.	Of	these	35	persons,	23	also	
had	clinical	DI	in	their	permanent	teeth.		Two	persons	with	a	history	of	DI	in	their	primary	teeth	had	
clinically	 normal	 permanent	 teeth.	 In	 10	 young	 patients	with	 no	 permanent	 teeth	 and	DI	 in	 their	
primary	 teeth,	 it	 was	 impossible	 to	 predict	 if	 the	 condition	 would	 manifest	 in	 their	 secondary	
dentition.		
The	 5	 CMA	 patients	 had	 the	 phenotypic	 features	 of	 classical	 OI	 III,	 specifically	 severe	 fracturing,	
stunted	stature,	white	sclerae	and	moderate	to	severe	DI.	Their	general	health	was	reasonably	good	
and	longevity	was	a	major	factor.	One	person,	the	prototypic	OI	III	patient	described	in	SA,	was	now	










By	 reason	 of	 their	 similarity	 to	 OI,	 three	 very	 rare	 autonomous	 genetic	 thin	 bone	 disorders,	 Pyle	
Disease,	 Osteolysis	 (Torg-Winchester	 Syndrome)	 and	 Osteoporosis-pseudoglioma	 Syndrome	 were	








Dentinogenesis	 imperfecta	 is	 subclinical	 in	 patients	 with	 the	 homozygous	 and	 compound	
heterozygous	mutations	in	exon	5	of	FKBP10.	The	clinical	manifestation	of	DI	in	the	primary	dentition	
was	not	a	predictive	indicator	that	the	permanent	dentition	would	also	be	affected.	
In	 South	 Africa,	 a	 developing	 country,	 the	 allocation	 of	 resources	 in	 terms	 of	 specialized	 dental	
facilities	is	limited.	Socio-economic	barriers	also	exist	with	patient	access	to	dental	care.		
The	previously	neglected	dental	and	craniofacial	abnormalities	documented	in	this	study	emphasizes	
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chromosome.	A	mutation	 that	 occurs	 in	 the	 gametes	 is	 inherited;	 a	mutation	 in	 the	 somatic	 cells	
(somatic	mutation)	is	not	inherited	
Phenotype:	 The	 appearance	 (physical,	 biochemical,	 and	physiological)	 of	 an	 individual	 that	 results	
from	the	interaction	of	the	environment	and	the	genotype	

















































































investigations,	 three	 other	 rare	 genetic	 thin	 bone	 disorders,	 which	 closely	 resembled	 OI	 III	 were	






in	which	 involvement	of	 the	bones,	 joints	and	skin	predominate.	 	Numerous	autonomous	variable	















Africa	 (SA).	 	The	clinical	and	genealogical	 studies	were	underpinned	by	biochemical	and	molecular	
investigations	in	the	DHG.		Pertinent	data	were	archived	and	remained	available.		During	the	course	
of	 these	 investigations,	 other	 important	 IDCTs	 which	 presented	 in	 SA,	 were	 delineated.	 	 These	
investigations	 facilitated	 diagnostic	 precision	 and	 accurate	 genetic	 counselling	 and	 they	 had	 an	
important	translational	component.		Provision	of	these	services	continues	through	the	DHG.	
1.1.2	Dental	Genetics	in	Cape	Town	
Links	between	 the	DHG,	UCT	and	 the	 Faculty	of	Dentistry,	University	of	 the	Western	Cape	 (UWC)	
commenced	in	the	1990s	when	Dr	Lawrence	Stephen	of	UWC	undertook	a	PhD	project	at	UCT.		
In	2002,	a	weekly	collaborative	UWC-UCT	Special	Dental	Genetic	 clinic	was	established	at	 the	Red	







affected	 persons	were	 documented.	 The	 physicians	 caring	 for	 the	 patients	 had	 requested	 routine	
molecular	genetic	investigations	which	were	undertaken	by	DHG	at	UCT.	Where	appropriate,	these	
findings	were	made	available	to	the	author.			





the	 Black	 African	 population	 of	 SA	 for	 the	 purpose	 of	 alerting	 the	 dental	 fraternity	 to	 possible	
complications	and	appropriate	management.		
During	 the	active	phase	of	 this	project,	 the	author	was	 introduced	 to	5	 individuals	of	Cape	Mixed	
Ancestry	 (CMA)	 heritage	 who	 presented	 with	 an	 OI	 III	 phenotype	 and	 significant	 dental	 and	
craniofacial	abnormalities.	Three	affected	 Indian	persons	with	a	putative	autosomal	 recessive	 (AR)	
form	of	OI	were	also	encountered	by	 the	author	at	 clinics	 in	KwaZulu	Natal.	Both	 these	groups	of	
individuals	are	included	in	this	study	but	are	documented	separately.		
Three	 rare	 genetic	 thin	bone	disorders,	 Pyle	Disease,	Osteolysis	 (Torg-Winchester	 Syndrome),	 and	
Osteoporosis-pseudoglioma	Syndrome,	were	also	recognized	in	patients	at	clinics	 in	KwaZulu	Natal	
and	RXH.	In	view	of	their	clinical	overlap	with	OI	III,	and	the	fact	that	all	three	disorders	were	initially	






















	This	 thesis	 is	divided	 into	6	 sections	and	20	 chapters.	 Each	 chapter	begins	with	a	 short	preamble	
outlining	the	contents	and	relevant	background	information.	The	appendix	includes	13	appendices.	
Dental	 concepts	 relevant	 to	 this	 study,	 tooth	 numbering,	 tooth	 anomalies,	 occlusion	 and	 a	 brief	
description	of	cephalometrics	are	also	included	also	in	the	appendix	(Appendices	2,	3,	4	and	6).		Teeth	
are	numbered	 and	 referred	 to	 according	 to	 the	 system	proposed	by	 the	 FDI	 (Féderation	Dentaire	




















Dental,	 	 craniofacial	 and	molecular	 findings	 in	 the	OI	 III	 affected	 individuals	 are	 presented	 in	 this	





molecular	 data	 of	 the	 CMA	 persons	 are	 described	 and	 discussed	 in	 Chapter	 11.	 The	 craniofacial	






The	management	 of	OI	 III	with	 bisphosphonate	 therapy	 is	 relevant	 to	 the	 dental	 and	 craniofacial	
management	 of	 the	 affected	 individuals	 due	 to	 possible	 orodental	 complications	 notably	
osteonecrosis	of	the	jaws.		
Dentinogenesis	imperfecta	(Chapter	15)	
Abnormality	 of	 the	dentition	 in	 terms	of	 colour	 of	 the	 teeth	 is	 an	 important	 orodental	 feature	 of	
several	forms	of	OI.	In	this	context	it	was	considered	relevant	to	review	the	current	literature,		provide	
an	update	on	the	classification	and	discuss	hereditary	dentine	disorders	(HDD)	in	detail.		






thin	 bone	 skeletal	 disorders	 which	 can	 mimic	 OI	 III,	 specifically	 Pyle	 Disease,	 Osteolysis	 (Torg-























the	 persons	 condition	 were	 analysed.	 Participation	 in	 the	 study	 was	 on	 a	 voluntary	 basis	 and	 all	
participants	were	 informed	that	 they	had	 the	option	 to	discontinue	 their	 involvement	at	any	 time	
Chapter	1:	Introduction	and	Overview	of	the	Thesis	
	 7	









descended	 from	 the	 indigenous	 Khoisan	 who	 lived	 in	 the	 Cape,	 individuals	 from	 Angola	 and	
Mozambique,	Javanese	from	the	former	Dutch	East	India	Company	and	European	Whites.	
The	majority	of	 South	Africa's	Asian	population	 is	 Indian	 in	origin,	many	of	 them	descended	 from	
indentured	workers	brought	 to	work	on	 the	 sugar	plantations	of	what	was	 then	Natal	 in	 the	19th	
century.		


















































OI-tarda	 was	 well	 established.	 In	 OI-congenita,	 the	 consistent	 normality	 of	 the	 parents	 and	 the	
occasional	recurrence	in	siblings	was	suggestive	of	autosomal	recessive	(AR)	inheritance.	By	the	late	































and	 an	 expanded	 Sillence	 classification	was	 published	 in	 2004	 (Rauch	 and	 Glorieux,	 2004).	 These	
authors	 added	 OI	 Types	 V	 –	 VII	 which	 had	 unknown	 genetic	 defects.	 Thereafter,	 following	
radiographic,	 bone	 morphologic	 and	 comprehensive	 molecular	 genetic	 analyses,	 an	 expanded	
classification	was	established.	This	is		presented	in	Table	II.2	(Steiner	et	al.,	2005).	
Table	II.2	Expanded	Classification	of	OI	(Steiner	et	al.,	2005)	
Type	 MOI	 Severity	 Fractures	 Bone	
Deformity	
Stature	 DI	 Sclerae	 Hearing	
Loss	










































V	 AD	 Moderate	 Multiple	with	
hypertrophic	callous	
Moderate	 Variable	 -	 N	 No	






















Table	 II.3	Category	25:	Osteogenesis	 imperfecta	 and	Decreased	 Bone	Density	Group	 (Warman	 et	 al.,	 2011)	
(modified	by	the	author	to	only	include	conditions	relevant	to	this	study)	
	
Name	of	Disorder	 MOI	 MIM	No.	 Locus	 Gene	 Protein	
OI,	non-deforming			
(OI	1)	















































The	Nosology	Committee	 suggested	 that	 the	Sillence	 classification	which	defined	and	 classified	OI	
according	 to	 clinical	 characteristics	 and	 inheritance	 pattern	 and	 not	molecular	 findings	 should	 be	
retained	in	clinical	practice	(Warman	et	al.,	2011).	This	recommended	‘Working	Nosology’	is	presented	
in	Table	II.4	and		Arabic	numerals	are	used	instead	of	Roman	numerals.		



















AR	 259450	 17q21	 FKBP10	 FK506	binding	protein	10	
Bruck	syndrome		
type	II	



















MOI	 MIM	No.	 Gene	 Protein	











































persons	 display	 the	 phenotypic	 consequence	 of	 this	 dominant	 mutation	 that	 alters	 the	 primary	





et	 al.,	 2012;	 Caparros-Martin,	 2013;	 Eyre,	 2013;	 Volodarsky	 et	 al.,	 2013;	 Rubinato	 et	 al.,	 2014).		
Mutations	in	WNT1	which	encodes	a	signalling	molecule	in	osteoblast	differentiation	and	proliferation	














α2	chains	are	processed	 in	 the	 rough	endoplasmic	 reticulum.	The	 three	chains	are	 then	aligned	 in	
order	 to	 commence	 folding	 into	 a	 triple	 helical	 structure.	 During	 this	 folding	 process,	 genetically	







Osteogenesis	 imperfecta	 has	 displayed	 marked	 genotypic	 variability,	 but	 the	 phenotypes	 remain	
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is	 the	 focus	of	 the	project	and	 it	 is	discussed	 in	detail	 in	 terms	of	history,	phenotypic	 features	and	













Swazi,	 Zulu	 and	 Tswana	 linguistic	 groups	 among	 others	 and	 a	 ratio	 of	OI	 I	 to	OI	 III	 as	 1	 to	 6	was	
estimated	in	this	population	group	(Viljoen	and	Beighton,	1987).	It	was	suggested	that	the	reason	for	





At	 birth,	 affected	 individuals	 present	 with	 multiple	 fractures	 and	 limb	 deformities.	 The	 fractures	
continue	 into	childhood	with	a	disturbance	of	growth	and	stunted	stature.	The	neck	and	trunk	are	
relatively	short	and	a	discrepancy	in	the	ratio	of	arm	span	to	height	is	consistently	found,	namely,	the	
arm	span	 is	more	extensive	 than	 the	height.	Kyphoscoliosis	 is	 a	 frequent	presentation	and	 is	 age-
related	with	the	majority	of	adults	having	severe	spinal	deformity	(Fig	3.1).	The	colour	of	the	sclerae	
may	be	blue	at	birth	 and	 infancy,	 but	 this	 fades	by	 I	 year	of	 age	and	 is	 then	described	as	normal	
(Sillence	 et	 al.,	 1986).	 Some	 affected	 persons	 survive	 into	 adulthood	 but	 experience	 progressing	
physical	disability	and	bone	deformity	even	in	the	absence	of	fractures	(Beighton	et	al.,	1983).	The	
bitemporal	 diameter	 may	 be	 wide,	 creating	 the	 appearance	 of	 a	 disproportionately	 large	 head	
(Beighton	and	Versveld,	1985).	Intellect	is	normal.	Death	usually	occurs	during	the	first	and	second	







Radiographic	 features	are	a	porotic	skeleton	and	the	consequences	of	multiple	 fractures.	The	 long	











Caries,	 attrition	 and	 tooth	 discolouration	 did	 not	 feature	 to	 the	 same	 extent	 in	 the	 permanent	































I	 collagen	 chains.	 Since	 2006	 a	 growing	 list	 of	mutant	 genes	 causing	 the	 5–10	%	 of	 AR	OI	 III	 has	





























































of	 Tswana	 heritage	 and	 termed	 the	 condition	 ‘Bruck	 Syndrome’.	 This	 prototype	 patient	 was	 also	
included	in	another	publication	by	Mokete	et	al.	(2005).	Biological	material	from	this	South	African	






phenotypic	 range	of	 severity	 that	may	 be	manifestations	 of	 intragenetic	 heterogeneity	within	 the	
FKBP10	gene.		The	BS	phenotype	has	widened	to	also	include	conditions	with	minimal	fracturing	and	
joint	 rigidity	 being	 a	 major	 feature.	 Further	 discussion	 of	 this	 complex	 and	 evolving	 nosological	
situation	is	outside	the	scope	of	this	thesis.		
Since	large	joints	develop	in	utero	in	a	flexion	position,	any	limitation	in	movement	will	result	in	a	lack	
of	 differentiation	 in	 the	 tissues	 developing	 around	 the	 joint	 (Barnes	 et	 al.,	 2013).	 It	 can	 be	
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Documentation	of	 the	dental	 and	 craniofacial	 phenotype	and	 the	 correlation	with	 the	genotype	 in	
affected	persons	is	a	major	objective	of	this	study.	During	this	project	specific	mutations	in	the	FKBP10	































is	 a	 chaperone	 protein	 which	 is	 important	 for	 the	 processing	 of	 collagen	 and	 elastin	 which	 are	







































which	 was	 described	 in	 isolated	 consanguineous	 groups	 of	 Yup’ik	 Inuits	 in	 southwest	 Alaska.	
Individuals	with	Kuskokwim	syndrome	have	normal	teeth.	A	homozygous	three-nucleotide	deletion	










Phenotypic	 information	 with	 regard	 to	 the	 orodental	 presentation	 and	 genotypic	 information	





















































































































2	 1	F	 Palestinian	 Y	 N	 Normal	 HOM:	(c.1271_1272delCCinsA)	


























































9	 1F	 Iranian	 Y	 N	 Normal	 HOM:	c.204delCinsAAA	







**These	 authors	 reported	 on	 38	 affected	 persons	 belonging	 to	 21	 families	with	mutations	 in	 the	
FKBP10	gene.	Eighteen	of	these	persons	had	the	BS	1	phenotype.(Schwarze	et	al.,	2014)		
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Clinical	 photographs	 were	 obtained	 in	 order	 to	 clearly	 depict	 the	 phenotype.	 When	 possible,	






























In	 April	 2013	 the	 active	 phase	 of	 the	 study	 began	 at	 centres	 in	 SA	 including	 Grey’s	 Hospital	 in	
Pietermaritzburg,	 Inkosi	 Albert	 Luthuli	 Central	 Hospital	 in	 Durban,	 University	 of	 the	 Free	 State	




















































in	 which	 OI	 III	 affected	 individuals	 received	 their	 bisphosphonate	 infusions.	 These	 persons	 were	
dentally	assessed.	
5.4.4	Free	State:	University	of	the	Free	State:	Qua	Qua,	Bethlehem	


















All	 affected	 persons	 that	 required	 dental	management	were	 identified	 and	 referred	 to	 colleagues	
practicing	 in	 or	 close	 to	 their	 areas	 for	 appropriate	 dental	 therapy.	 Provision	 for	 transport	 was	




























10).	 	Medical	 records	 were	 reviewed	 and	 clinicians	 provided	 clarity	 on	medical	 details	 that	 were	
difficult	to	obtain	from	the	patient	or	their	caregivers.	Written	permission	for	clinical	photographs	of	
the	affected	individual	were	obtained	from	the	patient	or	their	caregiver.		
Radiographic	 evaluation	 of	 an	 individual	 is	 an	 important	 facet	 of	 a	 comprehensive	 dental	 and	





Craniofacial	 imaging	 was	 undertaken	 when	 this	 resource	 was	 locally	 available.	 Panorex	 and	
cephalometric	 radiographs	were	 obtained	 and	 cone	 beam	 CT	 imaging	was	 also	 carried	 out	 when	




The	 imaging	 facilities	 used	 were	 only	 available	 at	 specific	 dental	 centres.	 The	 structure	 of	 the	
apparatus	used	is	described	and	depicted	in	detail	(Appendix	5)	 in	order	to	highlight	the	difficulties	










































































operating	 protocol.	 DNA	 was	 extracted	 from	 epithelial	 cells	 in	 saliva	 collected	 from	 affected	
individuals	 and	 analysed	 for	 a	 mutation	 in	 the	 FKBP10	 gene	 which	 has	 the	 cytogenetic	 location	
17q21.2.		
Although	molecular	 investigations	 were	 not	 an	 inherent	 component	 of	 this	 dental	 project,	 these	
results	 facilitated	appropriate	genetic	 counselling	and	management	of	 the	affected	 families	 in	 the	
genetics	clinic	of	DHG,	UCT	and	other	centres.				
	


































	 CHAPTER	 11:	 Cape	Mixed	Ancestry	 Persons:	General	Data,	Dental	 and	Molecular	
























captured	 in	 appropriate	 tables	 and	 analysed	 in	 this	 chapter.	 Individuals	 are	 represented	 by	
alphabetical-numerical	designations	pertaining	to	the	investigation	centre	and	the	chronological	order	
in	which	they	were	assessed.		

















For	 ethical	 reasons,	 patient	 identifiers	 were	 not	 mentioned	 and	 affected	 persons	 were	 given	 an	
























Affected	Individual	 Date	of	Birth	 Age		(Years)	 Gender	 Affected	Siblings	 Linguistic	Group	 Investigation	Centre	
BTHM	1	 22/01/1988	 25	 F	 1	 Zulu	 UOFS:BTHM	
BTHM	2	 19/11/2008	 6	 M	 1	 Sesotho	 UOFS:BTHM	
BTHM	3	 26/9/2004	 8	 F	 0	 Sesotho	 UOFS:BTHM	
BTHM	4	 13/06/2008	 6	 M	 0	 Sesotho	 UOFS:BTHM	
CPT	1	 11/12/1994	 19	 F	 0	 Xhosa	 UCT:GSH:CPT	
CPT	7	 26/07/1984	 30	 F	 0	 Xhosa	 UCT:GSH:CPT	
DBN	2	 08/08/1994	 19	 M	 0	 Zulu	 OAS:Dbn	
DBN	3	 12/06/1994	 19	 M	 1	 Zulu	 OAS:Dbn	
DBN	4	 01/01/1995	 18	 M	 0	 Zulu	 OAS:	Dbn	
DBN	5	 08/08/1994	 19	 M	 0	 Zulu	 OAS:	DBN	
DBN	7	 4/01/2012	 3	 M	 0	 Zulu	 IALCH:	Dbn	
DBN	8	 31/07/2012	 3	 F	 0	 Zulu	 IALCH:	Dbn	
DBN	10	 13/05/2013	 2	 F	 0	 Zulu	 IALCH:	Dbn	
DBN	11	 07/04/2010	 4	 M	 2	 Zulu	 IALCH:	Dbn	
DBN	12	 05/04/2011	 3	 F	 1	 Zulu	 IALCH:	Dbn	
DBN	13	 31/12/2009	 5	 F	 0	 Zulu	 IALCH:	Dbn	
DBN	14	 22/01/2002	 12	 F	 1	 Zulu	 	IALCH:	Dbn	
DBN	15	 20/01/2003	 11	 M	 0	 Zulu	 IALCH:	Dbn	
DBN	16	 26/09/2000	 14	 F	 1	 Zulu	 IALCH:	Dbn	
DBN	17	 25/05/2008	 6	 M	 0	 Zulu	 IALCH:	Dbn	
DBN	18	 18/06/1992	 20	 F	 0	 Zulu	 IALCH:	Dbn		
DBN	19	 04/06/2013	 2	 M	 1	 Zulu	 IALCH:	Dbn	
DBN	20	 27/10/2012	 3	 M	 0	 Zulu	 IALCH:	Dbn	
DBN	21	 31/07/2002	 12	 F	 0	 Zulu	 IALCH:	Dbn	
DBN	22	 11/10/2001	 13	 F	 1	 Sesothu	 IALCH:	Dbn	
MTH	1	 19/03/1997	 17	 M	 0	 Xhosa	 ILS	
MTH	2	 16/09/2000	 14	 M	 0	 Xhosa	 ILS	
MTH	3	 20/01/1993	 19	 M	 0	 Xhosa	 ILS	
MTH	4	 28/07/2003	 10	 F	 0	 Xhosa	 ILS	
































Table	VII.1	continued	when	examined	 Gender	 Affected	siblings	 Linguistic	Group	 Investigation	Centre	
PMB	1	 18/03/1998	 16	 F	 0	 Zulu	 GH:	Pmb	
PMB	2	 16/06/2003	 11	 F	 0	 Zulu	 GH:	Pmb	
PMB	3	 04/05/2007	 7	 M	 0	 Zulu	 GH:	Pmb	
PMB	4	 04/11/2010	 4	 F	 0	 Zulu	 GH:	Pmb	
PMB	5	 24/03/2008	 6	 M	 2	 Zulu	 GH:	Pmb	
PMB	6	 26/10/2010	 4	 M	 0	 Zulu	 GH:	Pmb	
PMB	7	 16/05/2005	 9	 F	 1	 Zulu	 GH:	Pmb	
PMB	8	 05/05/2000	 14	 M	 0	 Zulu	 GH:	Pmb	
PMB	9	 22/06/2008	 6	 F	 0	 Zulu	 GH:	Pmb	
PMB	10	 02/05/2011	 4	 M	 0	 Zulu	 GH:	Pmb	
PMB	11	 17/10/2001	 13	 F	 2	 Zulu	 GH:	Pmb	
PMB	12	 09/10/1999	 15	 M	 2	 Zulu	 GH:	Pmb	
PMB	13	 06/05/2008	 6	 M	 1	 Zulu	 GH:	Pmb	
PMB	15	 02/01/1995	 19	 F	 0	 Zulu	 GH:	Pmb	
PMB	16	 04/05/2010	 4	 F	 0	 Zulu	 GH:	Pmb	
PMB	17	 03/06/2010	 4	 M	 1	 Zulu	 GH:	Pmb	
PMB	18	 10/11/2010	 4	 F	 0	 Zulu	 GH:	Pmb	
PMB	19	 01/01/2005	 8	 F	 0	 Zulu	 GH:	Pmb	
PMB	21	 25/10/2011	 2	 F	 0	 Zulu	 GH:	Pmb	
PMB	22	 07/03/2011	 2	 F	 0	 Zulu	 GH:	Pmb	
PMB	23	 28/08/2003	 10	 F	 0	 Zulu	 GH:	Pmb	
PMB	24	 12/01/2003	 11	 F	 2	 Mpondo	 GH:	Pmb	
PMB	25	 16/12/1997	 17	 M	 0	 Zulu	 GH:	Pmb	
PRET	1	 13/03/2010	 4	 M	 2	 Shangan	 SBAH:	Pretoria	
PRET	2	 13/05/2011	 3	 M	 0	 Sesotho	 SBAH:	Pretoria	
PRET	3	 29/01/2007	 7	 F	 1	 Sepedi	 SBAH:	Pretoria	
PRET	4	 15/07/2003	 10	 M	 0	 Shona	 SBAH:	Pretoria	
PRET	5	 22/10/2005	 8	 F	 0	 Zulu	 SBAH:	Pretoria	
PRET	6	 13/02/2013	 1	 M	 0	 Sesotho	 SBAH:	Pretoria	
PRET	7	 13/08/2012	 2	 M	 1	 Zulu	 SBAH:	Pretoria	
QQ	1	 29/02/1988	 25	 F	 2	 Sesotho	 UOFS:	Qua	Qua	
QQ	2	 13/09/1984	 29	 M	 2	 Sesotho	 UOFS:	Qua	Qua	
QQ	3	 16/06/2003	 10	 F	 2	 Sesotho	 UOFS:	Qua	Qua	























Date	of	Birth	 Age	(Years)	 Gender	 Affected	
Relatives	
Investigation	Centre	
CPT	2	 20/04/1952	 62	 F	 0	 UWC:	Tyg:	CPT	
CPT3	 02/05/1993	 19	 F	 0	 UWC:	Tyg:	CPT	
CPT	4	 30/05/1986	 26	 F	 0	 UWC:	Tyg:	CPT	
CPT	5	 30/05/1986	 26	 F	 0	 UWC:	Tyg:	CPT	
CPT	6	 20/12/2001	 13	 F	 0	 UWC:	Tyg:	CPT	
Affected	
Individual	
Date	of	Birth	 Age	(Years)	 Gender	 Affected	
Relatives	
Investigation	Centre	
DBN	6	 11/08/1995	 17	 F	 0	 IALCH:	Dbn	
DBN	9	 22/11/2012	 2	 F	 0	 IALCH:	Dbn	















0	–	5	 20	 -	 1	
6	–	10	 16	 -	 -	
11	–	15	 14	 1	 -	
16	–	20	 9	 1	 2	
21	–	25	 3	 -	 -	
























DBN	5,	 the	5	 individuals	of	CMA	heritage	and	the	5	persons	 from	Umtata.	 It	 is	 suggested	that	 the	












	DI	was	 recorded	 based	 on	 the	 presence	 or	 absence	 of	 clinical	 discolouration	 of	 the	 teeth.	When	



































BTHM	1	 >5	 25	 92	 Walks	with	an	aid	 Y	 WT	 Y	 Y	
BTHM	2	 4	 6	 81	 Walks	with	an	aid		 Y	 WT	 Y	 Y	
BTHM	3	 >5	 8	 96	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
BTHM	4	 >30	 6	 79	 Cannot	walk	or	crawl	 Y	 WT	 Y	 Y	
CPT	1	 >10	 19	 119	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
CPT	7	 >50	 30	 105	 Chairbound	 N	 FKBP10_HET_c.[831dupC][1400-4C>G]	 N	 N	
DBN	2	 >20	 19	 107	 Chairbound	 N	 WT	 Y	 Y	
DBN	3	 >10	 19	 102	 Walks	with	an	aid		 N	 WT		 Y	 Y	
DBN	4	 8	 18	 103	 Walks	with	an	aid	 N	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
DBN	5	 >10	 19	 108	 Chairbound	 N	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
DBN	7	 >10	 3	 60	 Cannot	crawl		 Y	 WT	 Y	 ?	
DBN	8	 3	 3	 61	 Crawls	 Y	 WT	 Y	 ?	
DBN	10	 3	 2	 50	 Cannot	crawl	 Y	 WT	 Y	 ?	
DBN	11	 4	 4	 64	 Crawls	 Y	 WT	 Y	 ?	
DBN	12	 2	 3	 55	 Crawls	 Y	 WT	 N	 ?	
DBN	13	 >5	 5	 59	 Chairbound	 Y	 WT	 Y	 Y	
DBN	14	 >10	 12	 90	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
DBN	15	 >20	 11	 92	 Chairbound		 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
DBN	16	 >5	 14	 97	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
DBN	17	 >5	 6	 80	 Walks	with	an	aid	 Y	 WT	 Y	 Y	
DBN	18	 >20	 20	 114	 Chairbound		 Y	 WT	 Y	 Y	
DBN	19	 1	 2	 51	 Cannot	walk	or	crawl	 Y	 WT	 N	 ?	
DBN	20	 2	 3	 50	 Crawls	 Y	 WT	 Y	 ?	
DBN	21	 >30	 12	 75	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
DBN	22	 >10	 13	 80	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
MTH	1	 >10	 17	 100	 Chairbound		 N	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
MTH	2	(BS)	 >20	 14	 101	 Chairbound	 N	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
MTH	3	 >20	 19	 100	 Chairbound	 N	 WT	 Y	 Y	
MTH	4	(BS)	 >10	 10	 101	 Chairbound	 N	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
MTH	5	 >20	 20	 105	 Chairbound	 N	 WT	 Y	 Y	




PMB	1	(BS)	 >20	 16	 97	 Chairbound	 Y	 WT	 Y	 Y	
PMB	2	 >5	 11	 117	 Chairbound	 Y	 WT	 Y	 Y	
PMB	3	 >10	 7	 98	 Chairbound	 Y	 WT	 Y	 Y	
PMB	4	 3	 4	 68	 Crawls	 Y	 WT	 Y	 ?	
PMB	5	 >5	 6	 59	 Walks	with	an	aid		 Y	 WT	 Y	 Y	
PMB	6	 3	 4	 71	 Crawls	 Y	 WT	 Y	 ?	
PMB	7	 >10	 9	 90	 Cannot	walk	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PMB	8	 >10	 14	 118	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PMB	9	 >5	 6	 68	 Walks	with	an	aid	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PMB	10	 2	 4	 79	 Crawls	 Y	 WT	 N	 ?	
PMB	11	 3	 13	 100	 Walks	with	an	aid		 Y	 WT	 Y	 Y	
PMB	12	 >10	 15	 106	 Chairbound		 Y	 WT	 Y	 Y	
PMB	13	 >10	 6	 69	 Chairbound			 Y	 WT	 Y	 Y	
PMB	15	 >20	 19	 120	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PMB16	(BS)	 >5	 4	 89	 Cannot	walk		 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 ?	
PMB	17	 >5	 4	 94	 Crawls	 Y	 WT	 Y	 ?	
PMB	18	 >5	 4	 92	 Cannot	walk		 Y	 WT	 Y	 ?	
PMB	19	 >5	 8	 99	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PMB	21	 3	 2	 76	 Cannot	Crawl	 Y	 WT	 Y	 ?	
PMB	22	 >5	 2	 86	 Cannot	Crawl	 Y	 WT	 Y	 ?	
PMB	23	 >5	 10	 100	 Chairbound		 Y	 WT	 Y	 Y	
PMB	24	 >10	 11	 99	 Chairbound	 Y	 WT	 Y	 Y	
PMB	25	 >5	 17	 118	 Chairbound	 Y	 WT	 Y	 Y	
PRET	1	 >5	 4	 85	 Cannot	walk	or	crawl	 Y	 WT	 Y	 ?	
PRET	2	 >5	 3	 80	 Cannot	walk	or	crawl	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 ?	
PRET	3	 >10	 7	 82	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PRET	4	(BS)	 >10	 10	 93	 Chairbound		 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PRET	5	(BS)	 >10	 8	 95	 Chairbound	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 N	
PRET	6	 3	 1	 76	 Cannot	walk	or	crawl	 Y	 FKBP10_HOM_c.[831dupC][(831dupC)]	 N	 ?	
PRET	7	 3	 2	 84	 Cannot	walk	or	crawl	 Y	 WT	 Y	 ?	
QQ	1	 >20	 25	 119	 Chairbound	 Y	 FKBP10_HET_c.[831dupC];[831delC]	 N	 N	
QQ	2	 >20	 29	 115	 Chairbound	 Y	 FKBP10_HET_c.[831dupC];[831delC]	 N	 N	
QQ	3	 >10	 10	 118	 Walks	with	an	aid	 Y	 FKBP10_HET_c.[831dupC];[831delC]	 N	 N	


































CPT	2	 >50	 62	 96	 Chairbound	 N	 WT	 Y	 y	
CPT	3	 >30	 19	 93	 Chairbound	 N	 WT	 Y	 Y	
CPT	4	 >50	 26	 95	 Chairbound	 N	 WT	 Y	 Y	
CPT	5	 >50	 26	 95	 Chairbound	 N	 WT	 Y	 Y	



















DBN	6	 >15	 17	 115	 Walks	with	an	aid	 Y	 WT	 Y	 Y	
DBN	9	 >5	 2	 45	 Cannot	walk	or	crawl	 Y	 WT	 Y	 ?	









that	 essentially	 required	 pain	 control;	 these	 were	 not	 recorded.	 The	 quantity	 of	 fracturing	 in	 an	
individual	provided	a	perspective	on	the	severity	of	the	disorder.	In	turn,	severity	of	the	disorder	in	
the	 various	population	 groups	 could	be	 related	 to	 the	dental	 and	 craniofacial	 features	 and	 to	 the	
presence	or	absence	of	DI.		




Further	 analyses	 are	 outside	 the	 scope	 of	 this	 dentally	 orientated	 project	 but	 overall	 severity	 is	
highlighted	by	details	presented	in	Tables	VII.5,	VII.6	and	VII.7.					
The	5	individuals	of	CMA	heritage	whom	sustained	more	than	30	fractures	were	adults	aged	between	







The	 final	 height	 and	 general	 physical	 condition	 of	 the	 affected	 individuals	 are	 dependent	 on	 the	
number	of	 fractures	endured	as	well	 the	malalignment	of	 the	 limbs	due	 to	 the	malleability	of	 the	




























the	 Black	 African	 ethnic	 group	 of	 SA.	 This	 homozygous	 mutation,	 c.[831dupC];[(831dupC)],	 a	
frameshift	DNA	 variant	which	 is	 predicted	 to	 alter	 the	 protein	 sequence	by	 substituting	 a	Glycine	
residue	with	an	Arginine	at	position	278	of	the	65	kDa	FK506	Binding	protein	10.	This	is	achieved	by	
introducing	a	shift	in	the	reading	frame	which	results	in	the	introduction	of	a	premature	termination	
codon,	 95	 residues	 from	 the	 substitution	 point	 (NM_021939.3(FKBP10_i001):p.(Gly278Argfs*95)).	
The	introduction	of	this	premature	termination	codon	results	in	the	loss	of	211	amino	acid	residues.		















termination	 codon,	 20	 residues	 from	 the	 substitution	 point	





Another	 compound	 heterozygous	mutation,	 c.[831dupC][1400-4C>G]	 was	 identified	 in	 a	 29	 year	
Black	African	female	belonging	to	the	Xhosa	linguistic	group.	The	designation	‘c.1400-4c>g’,	means	





























therapy	 for	 the	 last	 5	 years.	 She	 had	 recent	 extractions	 of	 2	 molar	 teeth	 with	 no	 subsequent	
complications	despite	a	history	of	a	difficult	and	traumatic	procedure.			















































Bisphosphonates	 have	 an	 increased	 affinity	 for	 hydroxyapatite	 crystals	 which	 is	 the	
inorganic	constituent	of	bone	and	teeth	(Fleisch,	1998).	Longitudinal	studies	are	required	in	order	to	
evaluate	the	beginning	of	bisphosphonate	therapy	at	a	very	young	age	and	the	natural	history	of	DI	in	

















Osteogenesis	 imperfecta	type	III	 is	usually	not	lethal	 in	the	neonatal	period	but	growth	is	 impaired	
and	short	stature	is	usual	(Beighton	et	al.,	1983).		
In	 the	 past,	 death	 often	 occurred	 in	 persons	 with	 OI	 III	 during	 the	 first	 two	 decades	 of	 life.		
Management	of	OI	III	with	bisphosphonate	therapy	has	now	resulted	in	numerous	affected	individuals	
living	into	adulthood	(Sillence	et	al.,	1986).		
Prolonged	 life	 resulting	 from	 bisphosphonate	 therapy	 may	 influence	 the	 dental	 and	 craniofacial	
manifestations	as	these	features	are	age	related	(O’Connell	and	Marini,	1999).			






Both	 individuals	 received	bisphosphonate	 infusions	and	 their	molecular	 findings	 confirm	 that	 they	


































































































The	 clinical	 findings	 and	 a	 comprehensive	 account	 of	 the	 dental	 observations	 in	 the	 Black	 African	
population	group	of	affected	individuals	are	documented	in	this	chapter.	The	craniofacial	observations	
are	presented	and	commented	on	in	Chapter	9.	
The	 description	 and	 comment	 on	 the	 dentition	 in	 this	 chapter	 excludes	 the	 features	 of	 Hereditary	





Detailed	 clinical	 and	molecular	 findings	were	presented	 in	 Chapter	 7	 (Tables	VII.1,	 VII.2,	 VII.3	 and	














































































Zulu	 12	 0	 0	 26	
Xhosa	 4	 0	 1	 3	
Sesotho	 4	 3	 0	 3	
Sepedi	 2	 0	 0	 2	
Shona	 1	 0	 0	 2	
Shangan	 0	 0	 0	 1	
TOTAL	 23	 3	 1	 37	
	
	















individual.	 In	 addition,	 when	 radiographic	 resources	 were	 available,	 dental	 radiographs	 were	
obtained.			





DENTITION	 FKBP10		HOM:	n=20	 FKBP10_C	HET:	n=4	 WILD	TYPE:	n=36	
Abnormal	size	 0	 2	 2	
Abnormal	shape	 6	 2	 5	
Missing	teeth	 2	 0	 4	
Impacted	teeth	 5	 0	 10	























13	 individuals	with	abnormally	 shaped	 crowns	or	 roots,	 8	had	 features	of	 abnormal	 roots	 such	as	

































had	 a	 missing	 lower	 premolar,	 representative	 of	 partial	 anodontia.	 The	 prevalence	 of	 missing	
permanent	teeth	in	Sweden	and	Denmark	ranged	from	6.1%	to	7.8%	(Rolling,	1980).	After	the	analysis	


















between	 the	mesenchymal	and	ectodermal	 tissues	 takes	place.	 This	 suggests	 that	a	mesenchymal	
defect	may	 influence	 the	 incremental	 secretion	 and	mineralization	 of	 the	 enamel	 organic	matrix.	
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Affected	 individuals	 with	 OI	 III	 often	 exhibit	 characteristic	 craniofacial	 deformities	 encompassing	
abnormalities	of	 the	head	and	neck.	There	 is	 frequent	disharmony	between	the	mandible	and	the	
maxilla	which	eventually	results	in	functional	and	aesthetic	concerns	for	the	affected	person.		
The	 author	 is	 cognisant	 that	 within	 the	 Black	 African	 population	 each	 linguistic	 group	 may	 have	
genetically	determined	craniofacial	features,	but	the	identification	of	such	inherent	features	were	not	
pursued	in	this	project.		




In	 this	 project,	 occlusion	 was	 determined	 from	 a	 clinical	 oro-dental	 examination	 of	 the	 affected	
persons.	When	possible,	cephalometric	radiographs	were	obtained	in	order	to	confirm	a	skeletal-jaw	
relationship.	 Cephalometrics	 is	 the	 interpretation	 of	 lateral	 skull	 radiographs	 taken	 under	
standardized	 conditions.	 (see	 Appendix	 5	 for	 a	 summary	 of	 practical	 cephalometrics	 and	 the	
interpretation	of	cephalometric	values)	
Abnormalities	in	the	occlusion	and	skeletal	relationship	of	the	upper	and	lower	jaws	are	presented	
and	 summarized	 for	 each	 molecular	 group	 of	 Black	 African	 affected	 persons	 in	 Table	 XI.1.	 The	
occlusion	was	assessed	and	classified	from	a	craniofacial	and	dental	clinical	examination	and	when	






























1	 0	 11	 6							2	 4									10	 10	 8	
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0	 0	 1	 0								1	 0								1	 0	 1	
	
	












































































































































The	 craniofacial	 abnormalities	 are	 related	 to	 the	 abnormal	 bone	 matrix	 and	 consequent	 skeletal	
malleability	which	leads	to	a	deformed	skull.	The	affected	persons’	posture,	weight	and	size	of	the	
head	are	often	abnormal	and	these	variables	may	contribute	to	the	development	of	the	Skeletal	Class	
III	 malocclusion.	 A	 mandibular	 overjet	 (prognathic	 mandible)	 in	 individuals	 with	 OI	 III	 has	 been	



















may	 be	 an	 aetiological	 factor	 in	 the	 progressive	 development	 of	 a	 flattened	 palate.	 In	 turn,	 the	
flattening	of	the	palate	could	also	be	a	contributory	factor	to	the	development	of	cross	bites	and	open	
bites.				










Bitewing	 intraoral	radiographs	are	 ideal	 in	the	radiological	assessment	of	the	periodontium,	but,	 it	
was	imperative	to	minimize	the	radiation	exposure	levels	in	every	instance.	For	this	reason,	available	
panorex	and	CBCT	images	were	examined	and	periodontal	findings	were	reported.					
















































































Cephalometric	 radiographs	of	5	Black	African	affected	persons	were	obtained	as	 requested	by	 the	































radiographic	 access	was	 available.	 In	 cephalometric	 analyses	 of	 dentofacial	morphology,	 the	 sella	















turcica	 and	 OI	 but	 the	 author	 considers	 this	 a	 noteworthy	 finding	 despite	 an	 asymptomatic	
presentation.	 	 It	may	be	relevant	that	a	‘J’	shaped	sella	turcica	has	been	reported	in	Hajdu-Cheney	





Osteogenesis	 imperfecta	 type	 III	 is	 associated	with	 craniofacial	 abnormalities	 irrespective	 of	 their	
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Twenty	 three	 Black	 African	 affected	 persons	 were	 identified	 with	 the	 homozygous	 mutation	 in	
FKBP10.	No	clinically	obvious	features	of	DI	such	as	discoloured	or	translucent	teeth	were	evident	in	
the	 primary	 and	 secondary	 teeth	 of	 all	 twenty	 three	 individuals.	 These	 dental	 findings	 have	 been	
confirmed	by	means	of	intraoral	clinical	pictures	and	a	detailed	dental	history.	
	


















































Currently	he	 is	 able	 to	 stand	with	an	aid	but	 requires	a	 chair	 for	mobility.	He	experienced	 limited	
movement	and	sensation	in	his	left	arm	and	leg.		His	sclerae	were	white	and	the	colour	of	his	teeth	
was	normal	(Fig	10.3).		






































































The	 author	 proposes	 that	 the	 term	 dentinogenesis	 imperfecta	 (DI)	 be	 used	 to	 denote	 clinically,	
radiologically	and	histologically	aberrant	teeth	associated	with	OI	(see	Chapter	15).		













Versveld,	 1985).	 The	 dental	 findings	 in	 affected	 individuals	 in	 this	 study;	 although	 the	 teeth	were	
clinically	unaffected,	exhibited	a	range	of	radiological	manifestations	of	DI	which	range	from	severe	
to	mild.		
Several	 studies	have	shown	that	 teeth	with	no	apparent	clinical	DI	 in	association	with	OI,	do	have	
radiological,	 histological	 and	 electron	microscopic	 abnormalities	 of	 dentine	 (Lygidakis	 et	 al.,	 1996;	
Salvolini	et	al.,	1999;	Malmgren	and	Lindskog,	2003).	Discolouration	of	teeth,	should	therefore,	not	be	
the	minimal	criterion	for	the	diagnosis	of	DI.		

















































Radiographs	were	 necessary	 for	 a	 thorough	orodental	 evaluation,	 but	 these	 proved	 impossible	 to	








deposits	of	 subgingival	plaque	but	no	apparent	bone	 loss.	Given	 the	challenges	 in	 terms	of	dental	
















status	 had	 phenotypically	 normal	 teeth	 in	 terms	 of	 clinical	 colouration.	 The	 lack	 of	 radiological	
equipment	 at	 the	 centres	 where	 these	 individuals	 were	 examined	 and	 the	 difficulty	 in	 obtaining	








Black	African	 individuals	 in	SA	with	 the	homozygous	and	compound	heterozygous	mutation	 in	 the	
FKBP10	 gene	 have	 clinically	 unaffected	 teeth	 yet	 exhibited	 radiographic	 features	 of	 DI	 to	 varying	
degrees.	This	characterization	is	suggestive	of	a	relationship	between	the	genetic	abnormality	and	the	


















affected	 persons	with	 only	 some	 clinically	 discoloured	 teeth	 (Fig	 10.12),	 dental	 radiographs	were	
obtained	and	features	of	DI	were	confirmed	in	all	teeth	(Fig	10.13).	
Affected	 person	 DBN	 2	 reported	marked	 discolouration	 and	 attrition	 of	 all	 his	 primary	 teeth.	 His	
permanent	teeth	were	less	severely	involved	and	there	was	mild	discolouration	in	some	teeth	with	a	

































the	 secondary	 dentition	 compared	 with	 n=34	 in	 the	 primary	 teeth	 (Table	 X.1).	 The	 absence	 of	
radiographic	confirmation	in	most	cases	also	contributes	to	this	discrepancy.				
OI	is	a	genetically	heterogeneous	disorder	and	it	is	the	consequence	of	mutations	at	an	intracellular		



























A	 clinical-radiological	 score	 (CRS),	 created	by	 Scandinavian	 authors	was	employed	 (Malmgren	 and	










CRS	 FKBP10	(HOM)	 FKBP10	(C_HET)	 WT	
1	 0	 0	 0	
2	 4	 0	 0	
3	 0	 0	 0	
















dentin.	 The	 findings	 of	 this	 project	 in	 terms	 of	 DI	 are	 consistent	 with	 the	 observations	 of	 the	
Scandinavian	study	(Malmgren	and	Lindskog,	2003).		
These	authors	further	concluded	that	the	degree	of	dysplastic	dentin	correlated	with	severity	of	the	












mantle	 dentin	 for	 dysplastic	 changes.	 Reports	 suggest	 that	 the	degree	of	 dysplastic	 change	 varies	
between	these	areas	 in	a	 tooth	with	radicular	dentin	exhibiting	the	most	severe	dysplastic	change	
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orodental	 features.	 The	 general	 investigation	 findings,	 with	 the	 emphasis	 on	 dental	 features,	 in	





descended	 from	 the	 intermarriage	 of	 white	 settlers,	 African	 indigenous	 people	 and	 Asian	 slaves	
brought	to	SA	from	Dutch	colonies.	












































CPT2	 20/04/1952	 62	 5	 F	 >50	 96	 Chairbound	
CPT3	 02/05/1993	 21	 0	 F	 >50	 93	 Chairbound	
CPT4	 30/05/1986	 28	 0	 F	 >50	 95	 Walks	with	an	aid	
CPT5	 30/05/1986	 28	 0	 F	 >50	 95	 Walks	with	an	aid	
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the	 age	 of	 22	 years,	 she	 was	 documented	 as	 being	 105cm	 in	 height	 with	 severe	 scoliosis	 and	
pronounced	 bowing	 of	 the	 femora	 and	 humeri.	 At	 that	 time	 she	walked	with	 the	 aid	 of	 long	 leg	
callipers	and	crutches	(Fig	11.1)	and	she	had	minimal	bluing	of	the	sclerae.		
In	 2014,	 person	 CPT	 2	 was	 re-examined	 by	 the	 author	 and	 her	 clinical	 manifestations	 were	
documented.	She	was	chairbound;	96	cm	in	height	(Fig	11.2),	her	teeth	were	discoloured	and	showed	



























was	 made	 available	 to	 the	 author	 (Fig	 11.6)	 and	 a	 CBCT	 was	 requested	 by	 the	 attending		
prosthodontist.		



























































a	 younger	 unaffected	 female	 sibling.	 Her	 parents	 stated	 that	 she	 had	 a	 dental	 history	 of	 severe	
discolouration	of	her	primary	teeth	with	marked	attrition	and	early	loss.	Her	secondary	teeth	were	all	

















brown	 and	 they	 were	 opalescent.	 There	 was	 chipping,	 fracture	 and	 focal	 loss	 of	 the	 enamel.	
Radiographic	images	confirmed	the	presence	of	bulbous	crowns	and	almost	complete	obliteration	of	
the	pulp	chambers.	The	roots	of	the	teeth	were	thin	and	short.	































































The	 craniofacial	 and	 periodontal	 manifestations	 of	 the	 5	 CMA	 persons	 are	 described	 and	
















in	 persons	 with	 OI	 III	 (O’Connell	 and	 Marini,	 1999;	 Waltimo-Siren	 et	 al.,	 2005).	 The	 abnormal	
craniofacial	 and	 occlusal	 development	 hinder	 chewing	 and	 compromise	 aesthetics.	 Orthognathic	
surgery	maybe	necessary	for	the	correction	of	these	occlusions	(Kindelen	et	al.,	2003).		
Occlusal	 status	 is	 determined	 clinically	 and	 radiographically,	 in	 particular	 cepahlometrics.	
Cephalometric	values	(see	Appendix	5)	define	the	type	of	malocclusion	and	enable	the	identification	
of	either	a	true	or	relative	skeletal	or	dental	Class	III	malocclusion.		
A	 ‘relative	class	 III’	malocclusion	has	been	described	by	Waltimo-Siren	et	al.	 (2005)	and	suggests	a	
concordant	 relationship	 in	 size	 between	 the	maxilla	 and	mandible.	 Reductions	 in	 the	 vertical	 jaw	
dimensions	have	been	observed	in	individuals	with	OI	III	and	it	has	been	suggested	that	this	a	cause	
of	the	relative	mandibular	prognathism.	These	researchers	proposed	that	it	may	be	beneficial	to	OI	III	
affected	 individuals	 to	 have	 their	 dento-alveolar	 height	 increased	 by	 orthodontic	 means.	 This	




















Bitewing	 intraoral	radiographs	are	 ideal	 in	the	radiological	assessment	of	the	periodontium,	but,	 it	
was	imperative	to	minimize	the	radiation	exposure	levels	in	every	instance.	For	this	reason,	available	
panorex	and	CBCT	images	were	examined	and	periodontal	findings	were	reported.					
The	 periodontal	 status	 was	 assessed	 clinically	 by	 measuring	 the	 plaque	 and	 gingival	 indices,	
periodontal	pocket	depths	and	by	radiographical	investigations.		
The	4	individuals	showed	a	radiographic	absence	of	the	lamina	dura	and	had	an	average	pocket	depth	
of	 4.5mm.	 Clinically,	 interdental	 and	 subgingival	 plaque	 and	 calculus	was	 evident	 	 in	 each	 person	




related	 to	 their	malocclusion	and	difficulty	 in	accessing	all	areas	of	 the	mouth	during	oral	hygiene	






alveolar	 cortical	 bone	 which	 may	 aggravate	 the	 progression	 of	 periodontal	 disease	 once	 plaque	











































irregularities	 in	 the	 anatomy	 of	 the	 articular	 components	 of	 her	 TMJ.	 She	 was	 referred	 to	 a	
physiotherapist	for	further	management.		 	
The	condyle	of	the	mandible	and	the	base	of	the	skull	undergo	endochondral	ossification,	similar	to	











Assessments	 of	 the	 sinuses	 included	 a	 clinical	 history	 and	 an	 evaluation	 of	 CBCT	 images.	 	 All	 the	
affected	persons	gave	a	history	of	difficulty	breathing	and	recurrent	sinus	infections.		



























































































































2. Nelson,	 S.J.,	 Ash,	M.M.	 2010.	Wheeler’s	 Dental	 Anatomy,	 Physiology,	 and	 Occlusion,	 9th	 edn,	
Saunders	Elsevier,	St	Loius,	Missouri.	pp	272.	































The	majority	of	South	Africa's	Asian	population	 is	 Indian	 in	origin	who	descended	from	indentured	
workers	brought	by	the	British	Colonial	Government	to	work	on	the	sugar	plantations	of	Natal	in	the	
19th	century.	These	individuals	were	predominantly	Bengalis	and	Tamils	who	came	via	Kolkata	and	






During	 the	 survey	 of	 OI	 III,	 3	 persons	 of	 Indian	 heritage	 with	 DI,	 skeletal	 fragility	 and	 ocular	
involvement	 were	 introduced	 to	 the	 author.	 They	 are	 included	 in	 this	 study	 and	 their	 general	





















DBN6	 11/08/1995	 19	 0	 F	 >15	 112	 Walks	 with	
an	aid	
DBN9	 22/11/2012	 2	 0	 F	 >5	 50	 Cannot	
crawl/walk	










background.	 They	 both	 had	 limited	 oral	 opening	 and	 their	 permanent	 teeth	 were	 yellow	 and	
translucent	consistent	with	the	clinical	features	of	moderate	DI.		They	gave	a	history	of	severe	DI	in	
their	primary	teeth.	



















































She	 had	 mild	 mandibular	 prognathism	 and	 she	 was	 undergoing	 orthodontic	 treatment	 for	 the	
malalignment	of	her	teeth.		Her	dental	history	was	also	suggestive	of	severe	DI	in	her	primary	teeth	
with	early	exfoliation.	








































history	 of	 consanguinity	 could	 not	 be	 established	 it	maybe	 relevant	 that	 the	 progenitors	 of	 both	
individuals	hailed	from	Gujerat	province	of	India.		
Although	 rare,	Osteoporosis-pseudoglioma	 Syndrome	 (OPPG)	 has	 been	 documented	 in	 individuals	
from	Gujerat	(Beighton	et	al.,	1985,	Gong	et	al.,	1996)	and	in	their	descendants	born	in	South	Africa	
(see	Chapter	18).	Individuals	DBN	6	and	PMB	20	were	not	investigated	for	OPPG,	but	the	possibility	
that	 these	 individuals	 actually	 have	 OPPG,	 cannot	 be	 discounted.	 An	 attempt	 to	 contact	 their	
ophthalmologists	 by	 the	 author	 was	 unsuccessful.	 An	 ophthalmic	 opinion	 and	 further	 molecular	
investigations	are	warranted.		
The	 other	 recognized	 disorder	 to	 be	 associated	with	 eye	 abnomalities	 and	 vertebral	 compression	








































































































































































craniofacial	 management	 of	 the	 affected	 individuals.	 In	 particular,	 bisphosphonate	 induced	
osteonecrosis	of	the	jaws	is	a	rare	but	potentially	devastating	problem.	The	majority	of	the	persons	
with	OI	 III	 in	 this	 study	 had	 received	 or	were	 currently	 receiving	 bisphosphonate	 therapy.	 There	 is	
concern	 and	 uncertainty	 among	 members	 of	 the	 dental	 fraternity	 regarding	 management	 and	






has	 been	 the	 implementation	 of	 bisphosphonate	 therapy.	 These	 are	 synthetic	 analogs	 of	
pyrophosphate	which	inhibit	bone	resorption	by	being	deposited	on	the	bone	surface	and	are	ingested	




of	 OI	 III	 and	 the	 fracture	 rate	 has	 usually	 diminished.	 Nevertheless,	 bisphosphonate	 therapy	 has	
generally	 had	 little	 effect	 on	 the	 progression	 of	 the	 condition	 in	 OI	 III	 affected	 individuals	with	 a	
mutation	in	the	FKBP10	gene.	These	findings,	as	demonstrated	by	illustratrations	of	siblings	QQ	2	and	
QQ	3	 (see	Chapter	7)	 are	consistent	with	 those	described	by	Sillence	 in	which	he	states	 that	OI	 III	
affected	persons	with	a	mutation	in	the	FKBP10	gene	do	not	respond	optimally	to	cyclic	intravenous	
bisphosphonate	therapy,	particularly	Pamidronate.	There	are	no	reported	instances	of	Pamidronate	
















The	 jaws	 are	 susceptible	 to	 osteonecrosis	 due	 to	 several	 anatomical	 and	 physiological	 factors.	
Bisphosphonates	tend	to	accumulate	in	the	bones	of	the	jaws	due	to	the	high	vascularity	and	turnover	
rate.	The	forces	of	mastication	and	consequent	tension	on	the	periodontal	ligament	ensures	a	high	












Members	 of	 the	 dental	 fraternity	 such	 as	 restorative	 dentists,	 periodontists,	 orthodontists	 and	
maxillofacial	 surgeons	 often	manage	 children	with	 OI	 III	 on	 bisphosphonate	 therapy	 and	 it	 is	 the	
author’s	experience	that	there	is	uncertainty	as	to	how	to	manage	this	patient	group.	Trepidation	was	










Although	 bone	 graft	 surgery	 and	 dental	 implants	 are	 considered	 potential	 risk	 factors	 for	 the	
development	 of	 ONJ	 in	 individuals	 receiving	 bisphosphonate	 therapy,	 studies	 in	 this	 regard	 have	
reported	no	incidences	of	ONJ.	
14.2.2	Periodontics	
The	 potential	 beneficial	 effects	 of	 bisphosphonates	 on	 periodontal	 disease	 have	 been	 explored.	
Bisphosphonates	have	been	noted	to	have	paradoxical	effects	 in	 the	oral	cavity	with	the	potential	
beneficial	effects	on	periodontal	disease	by	increasing	the	density	of	alveolar	bone	and	yet	increasing	
the	 risk	 of	 ONJ	 (Borromeo	 et	 al.,	 2011). In	 OI	 III	 affected	 individuals,	 the	 lamina	 dura	 is	 absent	
suggesting	decreased	mineralization	of	the	alveolar	bone.	This	feature	places	these	persons	at	risk	for	





reported	 and	 the	 extraction	 of	 teeth	 is	 not	 contraindicated	 in	 these	 children	 (Brown	 et	 al.,	 2008;	
Schwartz	et	al.,	2008).	These	authors	suggest	that	age	may	be	a	protective	factor.	Increasingly,	adult	





orthodontic	 tooth	movement	 has	 been	 described	 in	 four	 cases	 with	 a	 history	 of	 bisphosphonate	
exposure	(Rinchuse,	2007;	Goss,	2008).	No	studies	have	specifically	implicated	orthodontic	treatment	











































(Ruggiero	 et	 al.,	 2009;	 Schwartz	 et	 al.,	 2008).	 In	 both	 circumstances,	 these	 authors	 recommend	
antibacterial	prophylaxis.	 		
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The	 features	 of	 the	 hereditary	 dentin	 dysplasias	 (HDD)	 are	 relevant	 to	 the	 dental	 findings	 in	 this	
project.	The	definition,	history	of	the	terminology	and	the	development	of	the	current	classification	is	






(DD)	 are	 a	 group	 of	 genetic	 conditions	 characterized	 by	 an	 abnormal	 dentin	 structure	 due	 to	
disturbances	in	the	formation,	composition,	or	organization	of	the	dentin	matrix	and	affects	either	the	
primary	 or	 both	 primary	 and	 secondary	 dentition	 to	 varying	 degrees.	 These	 disorders	 result	 from	
























The	 affected	 teeth	 are	 amber,	 brown	 or	 blue	 in	 colour	 (Fig	 15.2,	 Fig	 15.3).	Marked	 attrition	 and	



























clinical	 examination.	 Molecular	 diagnosis	 may	 be	 useful	 in	 the	 future	 as	 several	 disease	 causing	
mutations	have	been	identified.		Genetic	conditions	which	may	be	associated	with	HDD	are	listed	in	
Table	XV.1.	A	knowledge	and	awareness	of	these	conditions	and	their	possible	dental	manifestations	






















Schimke	 immune-osseous	 dysplasia	 (SIOD)	
[OMIM	242900]		
	


















Osteodysplastic	 and	 primordial	 short	
stature	 with	 severe	 microdontia	 and	




































any	 associated	 pathology.	 The	 causative	 gene	 anomaly	 has	 not	 as	 yet	 been	 identified	 and	 the	
pathological	process	is	not	understood.	
	Dentin	Dysplasia	Type	II	
The	 primary	 dentition	 shows	 features	 resembling	DI	 type	 II	 yet	 the	 permanent	 dentition	 is	 either	
unaffected	or	shows	mild	radiographic	anomalies	such	as	 ‘thistle	tube’	deformity	of	the	pulp.	Pulp	
stones	are	often	present.		



























125400	 DD	type	I	 Radicular	dentin	dysplasia	 Unknown	
125420	 DD	type	II	 DI:	Mild	form	 DSPP	
125490	 DI	type	II	 DI:	Moderate	form	 DSPP	


















Dentinogenesis	 imperfecta	 is	an	 inherited	disorder	affecting	dentin.	The	 resulting	defective	dentin	
manifests	as	discoloured	teeth	that	are	prone	to	attrition	and	fracture.		
Witkop	(1975)	proposed	a	new	classification	for	DI	which	suggested	that	DI	associated	with	OI	 is	a	
unique	 entity	 (Table	 XV.3).	 A	 recent	 review	 on	 the	 aetiology	 and	 nomenclature	 of	 DI	 and	 a	
presentation	of	a	case	of	Shields	DI	II	further	highlights	the	fact	that	DI	associated	with	OI	is	a	distinct	
disorder	which	is	clinically,	radiologically	and	histologically	similar	to	DI	associated	with	a	mutation	in	








Witkop	(1975)	 Revised	 according	 to	 Levin	
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Taurodontism	 is	 one	 of	 the	 manifestations	 of	 dysplastic	 dentin.	 This	 feature	 was	 identified	
radiographically	in	2	individuals	with	OI	III	and	the	boys	affected	with	Pyle	disease	and	Osteolysis.	











disturbance	of	 the	dentin	of	a	tooth.	 It	appears	most	frequently	as	an	 isolated	anomaly,	but	 its	


















alveolar	margin.	 Its	 distinguishing	 features	 can	 only	 be	 recognised	 from	diagnostic	 radiographs	
(Bharti	et	al.,	2009).		











This	 anomaly	 either	 can	 appear	 as	 an	 isolated	 trait	 or	 it	may	 be	 associated	with	other	 genetic	
syndromes	 such	 as	 hypophosphatasia,	 Klinefelter	 syndrome,	 Down	 syndrome,	 X-chromosome	
aneuploid	 syndrome,	 Mohr	 syndrome,	 tricho-dento-osseous	 syndrome	 and	 Maroteaux-Lamy	
syndrome	(Bhat	et	al.,	2004;	Jayashankara	et	al.,	2013).	
The	radiographic	characteristics	of	taurodont	tooth	are	an	extension	of	the	pulp	chamber	into	the	
elongated	body	of	 the	 tooth,	 shortened	 roots	and	 root	 canals	despite	a	normal	 crown	size	 (Fig	
16.2).	In	older	individuals	and	those	with	a	course	diet,	taurodontism	may	be	less	obvious	due	to	




early	 stage	 dentinogenesis	 since	 the	 pulp	 chambers	 may	 be	 large	 resembling	 those	 found	 in	
taurodontism.	In	children	and	young	adults,	the	developing	molars	may	have	radiographic	features	










Features	 of	 taurodontism	 were	 identified	 in	 DBN	 4,	 DBN	 6	 and	 2	 other	 individuals	 with	 an	
excessively	rare	thin	bone	disorders	namely	Pyle	Disease	and	Osteolysis	(see	Chapters	17	and	18).		




taurodontism	 in	 3	 of	 49	 persons	 with	 OI	 II	 and	 Malmgren	 and	 Norgren	 (2002)	 identified	
taurodontism	in	20	of	48	persons	with	OI.	
These	 observations	 suggest	 that	 diagnostic	 radiographs	 are	 important	 in	 the	 identification	 of	
taurodontic	teeth	in	persons	with	OI	III	in	order	to	deliver	preventive	dental	care.		
Further	studies	should	be	directed	towards	attempting	to	identify	the	incidence	of	taurodontism	








1. Ashwin,	R.,	Arathi,	 R.	 2006.	 Taurodontism	of	 deciduous	 and	permanent	molars:	 report	 of	 two	
cases.	J	Indian	Soc	Pedod	Prev	Dent.	1:42–4		





























During	 the	course	of	 the	 investigations,	 three	other	 rare	genetic	 thin	bone	disorders,	which	closely	

















































































































































































































Since	 the	 lower	 primary	 incisor,	 tooth	 51,	 had	 recently	 exfoliated,	 the	 author	 compared	 the	
ultrastructure	of	the	enamel	(Fig	17.13)	and	dentine	to	that	of	a	tooth	51	from	a	normal	child	using	a	
















































development	 and	 eruption	 of	 his	 permanent	 teeth.	 The	 available	 literature	 suggests	 that	 these	
findings	are	not	unique	to	the	boy	(Narayananan	et	al.,	2006).		








his	 molar	 teeth.	 Root	 canal	 treatments	 on	 mesotaurodontic	 teeth	 have	 proved	 a	 challenge	 (See	
Chapter	16	for	the	clinical	challenges	associated	with	taurodontism).		
Although	 the	 affected	 boy	 requires	 orthodontic	 treatment	 for	 maligned	 teeth,	 the	 progress	 and	
outcome	are	uncertain.	The	absence	of	the	lamina	dura	is	indicative	of	compromise	in	the	integrity	of	
the	periodontal	ligament.	A	healthy	periodontal	ligament	as	well	as	optimal	activity	of	osteoclasts	and	
osteoblasts	 is	 necessary	 for	 successful	 orthodontic	 therapy.	 In	 this	 context	 it	 is	 relevant	 that	 a	
histological	examination	of	a	section	of	bone	from	the	proximal	femoral	metaphyseal	area	revealed	
paucity	in	the	number	of	osteoclasts	(Percin	et	al.,	2003).		



















































of	 bone.	 This	 process,	 which	 is	 maximal	 in	 the	 articular	 regions	 of	 the	 limbs,	 leads	 to	 significant	









The	 nomenclature	 and	 classification	 of	 the	 Osteolyses	 was	 initially	 based	 upon	 the	 anatomical	
distribution	 of	 the	 affected	 regions	 and	 terms	 such	 as	 ‘carpo-tarsal	 osteolysis’	 and	 ‘multicentric	
osteolysis’	came	into	use.	With	the	delineation	of	specific	osteolysis	syndromes,	eponyms	were	also	
employed.	These	included	‘Winchester’	(Winchester	et	al.,	1969)	and	‘Torg’	(Torg	et	al.,	1969).		











active	 site	 of	 matrix	 metalloproteinase2	 gene	 (MMP2)	 and	 Rouzier	 et	 al.	 (2006)	 recorded	 a	
homozygous	MMP2	mutation	in	a	patient	diagnosed	with	Winchester	syndrome.		Thereafter,	Zankl	et	












Other	Osteolyses	which	were	 listed	 in	 the	 2010	 revision	 of	 the	 International	Nosology	 of	Genetic	
Skeletal	Disorders	(Warman	et	al.,	2011),	included	Familial	expansile	osteolysis,	Progeria	(Hutchinson-












features,	 underdeveloped	maxillary	 sinuses,	 a	 prognathic	 mandible,	 several	 impacted	 teeth,	 mild	
gingivitis	and	a	submucous	cleft	palate.	Zankl	et	al.	(2005)	described	the	clinical	features	of	an	Italian	






























































jaw	 resulted	 in	 discomfort.	 Due	 to	 an	 incomplete	 field	 of	 view,	 vertebral	 body	 evaluation	 was	
impossible.	Mild	generalized	osteoporosis	was	evident	and	asymmetry	of	the	craniofacial	structures	


















Delayed	development	of	 the	mandibular	 first	molars	with	only	 two-thirds	of	 root	 completion	was	
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The	 Osteoporosis-pseudoglioma	 syndrome	 (OPPG)	 [OMIM	 259770]	 is	 a	 rare	 autosomal	 recessive	
disorder	in	which	bone	fragility	and	frequent	fractures	are	associated	with	serious	ocular	changes.	The	
skeletal	manifestations	closely	resemble	those	of	osteogenesis	 imperfecta	while	hyperplasia	of	the	



















retardation	 (Neuhauser	 et	 al.,	 1986)	 and	with	 congenital	 heart	 disease	 (Teebi	 et	 al.,	 1988).	Other	






















caused	 OPPG.	 These	 authors	 stated	 that	 LRP5	 affects	 bone	 mass	 accrual	 during	 growth	 and	
heterozygous	carriers	of	the	mutant	LRP5	gene	have	reduced	bone	mass	when	compared	to	matched	
controls.	The	affected	individuals	fail	to	reach	an	adequate	peak	bone	mass	(Streeten	et	al.	 ,2008).	







is	 a	 homozygous	 frameshift	 mutation	 in	 XYLT2	which	 results	 in	 defective	 proteoglycan	 assembly	
(Munns	et	al.,	2015).	
The	 management	 of	 OPPG	 by	 administration	 of	 bisphosphonates	 and	 the	 success	 thereof	 was	
described	 by	 Bayram	 (2006).	 It	 has	 been	 recommended	 that	 patients	 with	 OPPG	 should	 begin	
treatment	with	bisphosphonates	within	the	initial	years	of	life	(Streeten	et	al.,	2008).	More	recently,	











The	 family	was	 initially	 investigated	 three	decades	ago	and	case	details	were	published	under	 the				












































- Mild	osteoporosis	was	 evident	 in	 the	 trabecular	 bone	of	 the	mandible.	 The	 cortical	 bone	was	
normal			 	
- Generalized	loss	of	trabeculation	of	cancellous	bone	has	resulted	in	enlarged	marrow	spaces	







































































































maxillary	 and	mandibular	 ridges.	His	 oral	mucosa	 overlying	 the	mandibular	 and	maxillary	 alveolar	
ridges	was	soft,	focally	erythematous	and	ulcerated.	He	had	worn	the	same	set	of	dentures	for	the	
last	15	years	and	his	diet	was	restricted	to	soft	easily	chewable	food.	


















































of	 the	 mandible	 displayed	 minimal	 osteoporotic	 changes	 when	 compared	 with	 the	 rest	 of	 the	
craniofacial	skeleton.	This	surprising	 finding	was	the	antithesis	of	what	was	observed	 in	other	 thin	





data	 are	 consistent	 with	 autosomal	 recessive	 inheritance.	 At	 the	 time	 of	 their	 diagnosis,	 genetic	
counselling	as	well	as	dedicated	medical	and	social	care	were	the	only	help	that	could	be	offered	to	


















dental	 radiographs	 which	 are	 routinely	 performed	 for	 dental	 diagnosis	 and	 procedures.	 This	
assessment	of	the	radiographic	density	enables	a	linear	measurement	(morphometric	analysis)	and	
an	 optical	 density	 measurement	 (densitometric	 analysis).	 The	 digitalization	 of	 the	 radiographs	
provides	a	further	tool	for	quantitatively	and	qualitatively	assessing	BMD	and	architecture.	A	digital	





Digital	 radiography	 enables	 the	 use	 of	 post-processing	 software	 to	 determine	 PI	 and	 panoramic	





general	medical	 literature	 suggested	 the	occasional	occurrence	of	micrognathia	 (Neuhauser	et	 al.,	
1976).	The	absence	of	dentinogenesis	imperfecta	in	the	South	African	Indian	family	was	specifically	
mentioned	 by	 Beighton	 et	 al.	 (1985).	 Swaboda	 et	 al.	 (1988)	 described	 carious	 primary	 teeth	 but	














Both	 AP	 1	 and	 AP	 2	 had	marked	 generalised	 osteoporosis	 and	 physical	 handicap	with	 associated	
blindness.		
AP	 1,	 being	 blind	 at	 birth	 had	 developed	 the	 skills	 essential	 to	 personal	 hygiene	 including	 tooth	






and	 mandible	 as	 evident	 by	 his	 BMD	 values,	 regular	 observation	 was	 advised	 with	 treatment	 to	
commence	only	if	the	teeth	or	his	temporomandibular	joint	became	symptomatic.		
AP	 2	 was	 chair	 bound,	 and	 difficulties	 in	 positioning	 were	 encountered	 in	 during	 the	 CBCT	
investigation.	In	particular,	it	was	necessary	for	him	to	be	raised	to	a	position	where	the	wheelchair	
did	not	inhibit	the	rotating	arm	of	the	machine.		
Following	 the	 clinical	 and	 radiological	 examinations,	 it	was	 decided	 that	 a	 new	denture	would	 be	
constructed	that	included	a	cushioned	base	to	ensure	stability	and	prevent	trauma	to	the	oral	tissues.	
He	was	advised	to	continue	on	a	soft	easily	digestible	diet.		
Dental	 treatment	 commenced	only	on	 confirmation	 that	his	 intraoral	 infections	were	 cleared	as	a	
previous	swab	of	the	erythematous	area	stained	positive	for	Candida	hyphae.	
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This	 final	 chapter	 encompasses	 the	 challenges	 confronted	 by	 dental	 practitioners	when	managing	














dysplasias	 in	 order	 to	 develop	 a	 treatment	 and	 maintenance	 plan	 and	 to	 facilitate	 timeous	
intervention.	The	challenges	encountered	during	this	process	are	discussed	below.	
Radiographs	
Radiographs	 are	 an	 important	diagnostic	 tool	 in	 the	evaluation	of	 an	 individual.	Optimal	 panorex,	
cephalometric	 and	 CBCT	 images	 were	 difficult	 to	 obtain	 due	 to	 the	 short	 stature	 and	 physical	












In	 addition	 to	 a	 short	 stature,	 several	 affected	 persons	 had	 kyphoscoliosis.	Many	 individuals	 had	
























When	present	 in	primary	 teeth,	DI	was	more	severe	and	 it	was	essential	 to	 try	and	prevent	 teeth	
breaking	down,	repair	them	as	necessary	and	attempt	to	maintain	the	teeth	until	the	secondary	teeth	
emerged.	 If	 the	 secondary	 teeth	 are	 also	 affected	 with	 DI,	 a	 dental	 material	 that	 is	 aesthetically	
pleasing	must	 be	 used.	 The	 patients	 should	 be	 observed	 closely	 and	 their	 teeth	 and	 restorations	


























Their	 short	 stature	and	bone	 fragility	 resulted	 in	difficulty	and	discomfort	during	 the	use	of	public	
transport.		





















It	 was	 the	 author’s	 experience,	 that	 DI	 affected	 persons	 were	 extremely	 concerned	 about	 the	
functional	and	cosmetic	condition	of	their	face	and	teeth.	There	are	several	articles	published	in	the	
dental	literature	that	documents	the	management	of	DI	(Stephen	and	Beighton,	2002;	Teixeira,	2008)	
















orthodontist,	 a	 maxillofacial	 surgeon,	 a	 prosthodontist	 and	 a	 periodontist,	 as	 determined	 by	 the	
patients’	needs,	would	be	necessary.		
The	heterogeneity	of	the	patient	population	emphasizes	the	requisite	multidisciplinary	approach	to	
developing	 a	 comprehensive	 treatment	 plan	 and	 monitoring	 progress.	 Unfortunately,	 economic	










fields	 of	 paediatric	 dentistry,	 periodontics,	 orthodontics,	 oral	 surgery,	 oral	 radiology	 and	






as	muscle	 activity,	 salivary	 secretion	 and	 quality	 of	 the	 oral	mucosa	 in	 individuals	with	 thin	 bone	
disorders.	To	the	best	of	the	author’s	knowledge	no	published	data	exists	on	the	insertion	of	dental	
implants	in	persons	with	these	disorders.			
Several	 reports	 describe	 the	 role	 of	 connective	 tissue	 cells	 such	 as	 osteoblasts,	 fibroblasts	 and	





























In	 addition	 to	 bisphosphonates,	 growth	 hormone	 has	 been	 shown	 to	 increase	 the	 bone	 mineral	
density	on	 its	own	 (Marini	et	al.,	2003)	or	 in	combination	with	bisphosphonates	 (Antoniazzi	et	al.,	
2010).	 In	these	projects,	however,	there	was	no	decrease	 in	the	rate	of	fracturing	(Bargman	et	al.,	





al.,	 2008).	 A	 small	 group	 of	 children	 with	 severe	 OI	 showed	minimal	 improvement	 in	 their	 bone	
phenotype	after	the	administration	of	mesenchymal	stem	cells	with	osteoblastic	potential	(Horwitz	et	





Denosumab	 is	 a	 receptor	 activator	 of	 nuclear	 factor-ĸB	 ligand	 inhibitors	which	 inhibits	 osteoclast	
formation	 and	 bone	 degradation.	 A	 study	 has	 shown	 that	 denosumab	 normalized	 the	 elevated	
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Impacted	teeth	are	 those	that	have	 failed	to	erupt	and	remain	buried	 in	 the	alveolar	bone	 (Fig	2).	












































functional	 occlusion.	 This	 bite	 is	 often	 present	 in	 persons	 with	 a	 dental	 and	 skeletal	 class	 III	
malocclusion.	An	edge	to	edge	bite	is	also	frequently	identified	in	children	with	only	deciduous	teeth	
and	in	those	that	are	in	the	mixed	dentition	period,	from	approximately	1.5	years	to	12	years.	This	









































the	 cranial	 base,	 the	 maxilla	 and	 mandible	 and	 maxillary	 and	 mandibular	 dentitions.	 All	
cephalometrics	analyses	describe	the	interrelationship	of	these	components	in	a	vertical,	horizontal	













‘Wits’	 appraisal	 which	 is	 the	 analyses	 used	 by	 the	 author	 in	 the	 interpretation	 of	 the	 various	
cephalometric	radiographs	of	the	affected	persons.			
Below	is	a	cephalometric	radiograph.	The	soft	tissue	outline	as	well	as	the	tongue	and	pharynx	are	







































































































Ba-N-A	 610	+/-	3	 M	 P	 R	
SNA	 810	+/-	3	 850	+/-	2	 M	 P	 R	
SNB	 800	+/-	2	 810	+/-	2	 M	 P	 R	
ANB	 20	+/-	2	 50	+/-	2	 I	 II	 III	



















	 N	 V	 H	
UFH	:	LFH	 45	:	55	
	





131mm	 114mm	 	 N	 P	 R	
Mx	incisor	:	NA		 220	 	 	 N	 P	 R	
Mx	incisor	:	NA		 4mm	 	 	 N	 P	 R	
Md	incisor	:	NB		 250	 	 	 N	 P	 R	
Md	incisor	:	NB		 4mm	 	 	 N	 P	 R	















































































































































































































Primary	 	 	 	 55	 54	 53	 52	 51	 61	 62	 63	 64	 65	 	 	 	
Secondary	 18	 17	 16	 15	 14	 13	 12	 11	 21	 22	 23	 24	 25	 26	 27	 28	
Secondary	 48	 47	 46	 45	 44	 43	 42	 41	 31	 32	 33	 34	 35	 36	 37	 38	
Primary	 	 	 	 85	 84	 83	 82	 81	 71	 72	 73	 74	 75	 	 	 	
	
Caries:	
Primary	 	 	 	 55	 54	 53	 52	 51	 61	 62	 63	 64	 65	 	 	 	
Secondary	 18	 17	 16	 15	 14	 13	 12	 11	 21	 22	 23	 24	 25	 26	 27	 28	
Secondary	 48	 47	 46	 45	 44	 43	 42	 41	 31	 32	 33	 34	 35	 36	 37	 38	











































































You	are	being	asked	 to	 take	part	because	you	have	a	confirmed	diagnosis	of	an	 inherited	
connective	tissue	disorder.	
How	will	the	study	be	carried	out?	
This	 study	 has	 a	 predominant	 clinical	 component	 in	 which	 dental	 and	 craniofacial	
abnormalities	 in	 affected	 persons	will	 be	 documented.	 The	 dental	 status	 of	 persons	with	
IDCTs	 attending	 the	UWC-UCT	 Special	 Dental	 Clinic,	 Red	 Cross	 Children’s	 Hospital	will	 be	
assessed	and	documented.	Investigation	of	persons	with	IDCTs	at	special	institutions	for	the	
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STUDY	TITLE:	Dental	 Implications	of	 Inherited	Connective	Tissue	Disorders	(ICTD’s)	 in	South	
Africa.	


















































2.	 I	understand	that	my	child	does	not	have	to	take	part	 in	 this	study	and	that	 I	can	have	
him/her	withdrawn	from	the	study	at	any	time.	I	understand	that	I	don’t	have	to	give	a	reason	
for	withdrawing	my	child	from	the	study	and	I	understand	that	withdrawing	my	child	won’t	
affect	his/her	future	medical	and	dental	care.																																		Yes…….									No…….	
3.	I	am	aware	of	the	potential	risks	of	this	research	study	to	my	child.							Yes…….								No…….					
4.	I	give	permission	for	researchers	to	look	at	my	child’s	medical	records	to	get	information.	I	
have	been	assured	that	the	information	about	my	child	will	be	kept	confidential.																
																																																																																																																								Yes…….							No…….	
5.	I	(parent/guardian)	have	been	given	a	copy	of	the	information	sheet	and	this	completed	
consent	form.																																																																																																				Yes…….								No…….	
Patient	Name	(minor):	………………………………………………………………………	
Parent	Name:	………………………………………………………………..	
Parent	signature:	…………………………………………………………………..	
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Child	assent	(7-17	years):	…………………………………………………………..	
Guardian	name:	………………………………………………………………….	
Guardian	signature:	……………………………………………………………	
To	be	completed	by	the	principal	Investigator	
I,	the	undersigned,	have	taken	the	time	to	fully	explain	to	the	above	patient	the	nature	and	
purpose	of	this	study	in	a	way	that	they	could	understand.	I	have	explained	the	risks	involved	
as	well	as	the	possible	benefits.	 I	have	invited	them	to	ask	questions	on	any	aspect	of	the	
study	that	concerned	them.	
Principal	Investigator	Name:	………………………………………………………………………	
Qualifications:	………………………………………………………………………	
Signature:	…………………………………………………………	
Date:	…………………………………………	
	
	
NB:	three	copies	to	be	made:	
- Research	participant	
- Principal	Investigator	
- Institution	records	
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PATIENT	CONSENT	TO	CLINICAL	PHOTOGRAPHS	AND	
PUBLICATION:	(Parent/Guardian	–	Child)	
TO	WHOM	IT	MAY	CONCERN	
I,	the	undersigned	
…………………………………………………………………………in	my	capacity	as	parent/guardian	consent	
to	photographs	being	taken	of	……………………………………………………………………..as	requested.	I	
understand	that	these	photographs	will	be	stored	appropriately,	treated	with	the	utmost	
confidentiality	and	be	part	of	my	child’s	dental	records.		
I	hereby	give	consent	for	the	images	of	my	child	to	be	used	ONLY	for	that	I	have	indicated	
with	a	tick:	
____	Record	purposes	and	for	my	child’s	future	management	
The	photographic	images	will	form	part	of	the	information	collected	for	your	child’s	care	
and	treatment	and	will	be	kept	confidential	at	all	times.		
____	Education	and	Training	purposes	
The	photographic	images	maybe	used	for	teaching	purposes	and	viewed	by	health	
professionals	outside	of	the	UWC	Faculty	of	Dentistry.	The	images	may	be	used	in	talks,	
conference	presentations,	posters	or	on	the	Internet	to	help	train	other	health	professionals	
in	the	management	of	dental	and	oral	diseases	
___	Approved	research	purposes	and	publications		
This	may	involve	the	photographic	images	being	used	in	medical	or	dental	publications,	
journals,	textbooks,	conference	material,	e-publications	and	on	the	Internet.	Images	will	be	
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seen	by	health	professionals	and	researchers	who	use	the	publications	in	their	professional	
education.	The	images	may	be	seen	by	the	general	public.	Images	will	not	be	used	with	
identifying	information	such	as	name,	however,	full	confidentiality	is	not	guaranteed.	
___	Other	Purposes	(please	specify):	………………………………………………………………………………..	
• I	understand	that	all	efforts	will	be	made	to	conceal	my	child’s	identity	but	that	full	
confidentiality	cannot	be	guaranteed	
• I	understand	that	my	consent	or	refusal	will	in	no	way	affect	my	child’s	dental	care	
	
Patient	Name	(print)……………………………………………………………………	
Parent/Guardian	if	patient	is	under	18	years	of	age	(print	name):	……………………………………	
Parent/Guardian	Signature:	………………………………………………………	
Date:	…………………………………………………	
Child	assent	(7-17	years):	…………………………………………………………..	
Principal	Investigator	print	name:	………………………………………………………………..	
Principal	Investigator	signature:	…………………………………………………………...									
Date:	…………………..…………….	
	
	
	
	
	
	
	
	
Requesting	Clinician	name	(print)……………………………………………………..…………………	
Date:	………………………..	Department:	…………………………………………..	Phone:	…………………………………………	
Patient	Name	(print):	………………………………………………………………………………………	
Views	Required:	…………………………………………………………………………………………………………………………………	
Required	for	(tick):	Records	____						Teaching/	Lectures____							Research____						Publication	____	
Images	taken	by:	………………………………………………………………….						Date:	…………………………………………..	
Location	where	copies	are	stored:	…………………………………………………………………………………………………..	
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PATIENT	CONSENT	TO	CLINICAL	PHOTOGRAPHS	AND	
PUBLICATION:	(Adult)	
TO	WHOM	IT	MAY	CONCERN	
I,	the	undersigned	
…………………………………………………………………………consent	to	photographs	being	taken	of	
myself	as	requested.	I	understand	that	these	photographs	will	be	stored	appropriately,	
treated	with	the	utmost	confidentiality	and	be	part	of	my	dental	records.		
I	hereby	give	consent	for	these	images	to	be	used	ONLY	for	that	I	have	indicated	with	a	tick:	
____	Record	purposes	and	for	my	future	management	
The	photographic	images	will	form	part	of	the	information	collected	for	your	care	and	
treatment	and	will	be	kept	confidential	at	all	times.		
____	Education	and	Training	purposes	
The	photographic	images	maybe	used	for	teaching	purposes	and	viewed	by	health	
professionals	outside	of	the	UWC	Faculty	of	Dentistry.	The	images	may	be	used	in	talks,	
conference	presentations,	posters	or	on	the	Internet	to	help	train	other	health	professionals	
in	the	management	of	dental	and	oral	diseases	
___	Approved	research	purposes	and	publications		
This	may	involve	the	photographic	images	being	used	in	medical	or	dental	publications,	
journals,	textbooks,	conference	material,	e-publications	and	on	the	Internet.	Images	will	be	
seen	by	health	professionals	and	researchers	who	use	the	publications	in	their	professional	
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education.	The	images	may	be	seen	by	the	general	public.	Images	will	not	be	used	with	
identifying	information	such	as	name,	however,	full	confidentiality	is	not	guaranteed.	
___	Other	Purposes	(please	specify):	………………………………………………………………………………..	
• I	understand	that	all	efforts	will	be	made	to	conceal	my	identity	but	that	full	
confidentiality	cannot	be	guaranteed	
• I	understand	that	my	consent	or	refusal	will	in	no	way	affect	my	dental	care	
	
Patient	Name	(print)……………………………………………………………………	
Patient	signature:	…………….……………………………………	
Principal	Investigator	print	name:	………………………………………………………………..	
Principal	Investigator	signature:	…………………………………………………………...									
Date:	…………………..…………….	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Requesting	Clinician	name	(print)……………………………………………………..…………………	
Date:	………………………..	Department:	…………………………………………..	Phone:	…………………………………………	
Patient	Name	(print):	………………………………………………………………………………………	
Views	Required:	…………………………………………………………………………………………………………………………………	
Required	for	(tick):	Records	____						Teaching/	Lectures____							Research____						Publication	____	
Images	taken	by:	………………………………………………………………….						Date:	…………………………………………..	
Location	where	copies	are	stored:	…………………………………………………………………………………………………..	
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CONSENT	FOR	DNA	ANALYSIS	AND	STORAGE	
	
1.	I,	……………………………………………………………………………………………………………..,	request	that	an	
attempt	be	made	using	genetic	material	to	assess	that	I	/	my	child	/	my	unborn	child	(delete	
where	not	applicable)	might	have	inherited	a	disease	causing	mutation	in	the	gene	for	
…………………………………………………………………………………………………………………………..	
2.	I	understand	that	the	genetic	material	for	analysis	is	to	be	obtained	from	blood	/	saliva	
(delete	where	not	applicable).	
3.	I	request	that	no	portion	of	the	sample	be	stored	for	later	use…………..	(tick	if	applicable)	
OR	
I	request	that	a	portion	of	the	sample	be	stored	indefinitely,	for	5	years,	for	1	year,	until	the	
study	is	completed	(delete	where	not	applicable)	for	
- Possible	re-analysis	
- Analysis	for	the	benefit	of	members	of	my	immediate	family	
- Research	purposes,	subject	to	the	approval	of	the	Research	Ethics	Committee,	
provided	that	all	information	will	remain	confidential	
4.	The	result	of	the	analysis	will	be	made	known	to	me,	via	my	doctor(s),	in	accordance	with	
the	relevant	protocol,	if	and	when	available.	
5.	If	clinically	relevant,	I	authorise	that	the	results	may	be	made	known	to	family	members.	
6.	I	have	been	informed	that:	
-	the	analysis	procedure	is	specific	to	the	genetic	condition	and	cannot	determine	the	
complete	genetic	make-up	of	an	individual.	
-	the	genetics	laboratory	is	under	an	obligation	to	respect	medical	confidentiality		
-	genetic	analysis	may	not	be	informative	for	some	families	or	family	members	
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-	even	under	the	best	conditions,	current	technology	of	this	type	is	not	perfect	and	could	
lead	to	incorrect	results	
-	where	biological	material	is	used	for	research	purposes,	there	may	be	no	direct	benefit	
to	me	
7.	I	understand	that	I	may	withdraw	my	consent	for	any	aspect	of	the	above	at	any	time	
without	this	affecting	my	future	medical	care.					
8.	All	of	the	above	has	been	explained	to	me	in	a	language	that	I	understand	and	my	
questions	answered	by:	
Doctor/Consultant:	…………………………………………………….								Date:	…………………………………………	
Patient/Parent:	…………………………………………………………..								Date:	…………………………………………	
	
Laboratory	Findings:	__________________________________________________________	
___________________________________________________________________________	
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________	
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